v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock and additional paid-in capital:
Accumulated deficit:
Accumulated other comprehensive income (loss):
Common stock
Beginning balances at Dec. 31, 2022 $ 419,024 $ 982,306 $ (560,310) $ (2,972)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   63,869      
Exercise of stock options   863      
Issuance of common stock under ESPP   3,459      
Settlement of capped calls   139      
Net loss (47,305)   (47,305)    
Other comprehensive income (loss)       978  
Ending balances at Sep. 30, 2023 441,027 1,050,636 (607,615) (1,994)  
Common stock, beginning balance (in shares) at Dec. 31, 2022         57,735
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)         32
Issuance of common stock under ESPP (in shares)         146
Shares issued for the vesting of restricted stock awards (in shares)         722
Common stock, ending balance (in shares) at Sep. 30, 2023         58,635
Beginning balances at Jun. 30, 2023 441,407 1,027,802 (584,448) (1,947)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   22,445      
Exercise of stock options   389      
Issuance of common stock under ESPP   0      
Settlement of capped calls   0      
Net loss (23,167)   (23,167)    
Other comprehensive income (loss)       (47)  
Ending balances at Sep. 30, 2023 441,027 1,050,636 (607,615) (1,994)  
Common stock, beginning balance (in shares) at Jun. 30, 2023         58,447
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)         13
Issuance of common stock under ESPP (in shares)         0
Shares issued for the vesting of restricted stock awards (in shares)         175
Common stock, ending balance (in shares) at Sep. 30, 2023         58,635
Beginning balances at Dec. 31, 2023 448,479 1,075,284 (625,694) (1,111)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   73,372      
Exercise of stock options   8,404      
Issuance of common stock under ESPP   3,044      
Settlement of capped calls   0      
Net loss (38,700)   (38,700)    
Other comprehensive income (loss)       518  
Ending balances at Sep. 30, 2024 $ 495,117 1,160,104 (664,394) (593)  
Common stock, beginning balance (in shares) at Dec. 31, 2023 59,031       59,031
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)         234
Issuance of common stock under ESPP (in shares)         95
Shares issued for the vesting of restricted stock awards (in shares)         1,041
Common stock, ending balance (in shares) at Sep. 30, 2024 60,401       60,401
Beginning balances at Jun. 30, 2024 $ 480,665 1,134,468 (652,597) (1,206)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense   25,636      
Exercise of stock options   0      
Issuance of common stock under ESPP   0      
Settlement of capped calls   0      
Net loss (11,797)   (11,797)    
Other comprehensive income (loss)       613  
Ending balances at Sep. 30, 2024 $ 495,117 $ 1,160,104 $ (664,394) $ (593)  
Common stock, beginning balance (in shares) at Jun. 30, 2024         60,283
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)         0
Issuance of common stock under ESPP (in shares)         0
Shares issued for the vesting of restricted stock awards (in shares)         118
Common stock, ending balance (in shares) at Sep. 30, 2024 60,401       60,401